Your browser doesn't support javascript.
loading
Diverse effects of interferon alpha on the establishment and reversal of HIV latency.
Van der Sluis, Renée M; Zerbato, Jennifer M; Rhodes, Jake W; Pascoe, Rachel D; Solomon, Ajantha; Kumar, Nitasha A; Dantanarayana, Ashanti I; Tennakoon, Surekha; Dufloo, Jérémy; McMahon, James; Chang, Judy J; Evans, Vanessa A; Hertzog, Paul J; Jakobsen, Martin R; Harman, Andrew N; Lewin, Sharon R; Cameron, Paul U.
Afiliación
  • Van der Sluis RM; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Zerbato JM; Aarhus Institute of Advanced Studies, Aarhus University, Aarhus, Denmark.
  • Rhodes JW; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Pascoe RD; School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Solomon A; Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, NSW, Australia.
  • Kumar NA; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Dantanarayana AI; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Tennakoon S; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Dufloo J; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • McMahon J; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Chang JJ; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Evans VA; Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, VIC, Australia.
  • Hertzog PJ; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Jakobsen MR; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Harman AN; Centre for Innate Immunity and infectious Disease, Hudson Institute of Medical Research, Clayton, VIC, Australia.
  • Lewin SR; Dept Molecular & Translational Sciences, Monash University, Clayton, VIC, Australia.
  • Cameron PU; Department of Biomedicin, Aarhus University, Aarhus, Denmark.
PLoS Pathog ; 16(2): e1008151, 2020 02.
Article en En | MEDLINE | ID: mdl-32109259
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transcripción Genética / Linfocitos T CD4-Positivos / Duplicado del Terminal Largo de VIH / VIH-1 / Interferón-alfa / Latencia del Virus Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2020 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transcripción Genética / Linfocitos T CD4-Positivos / Duplicado del Terminal Largo de VIH / VIH-1 / Interferón-alfa / Latencia del Virus Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2020 Tipo del documento: Article País de afiliación: Australia